Latham & Watkins represents The Vita Coco Company, Inc. in upsized secondary offering of common stock by selling stockholder. The Vita Coco Company, Inc., a leading...
The Vita Coco Company’s Common Stock Secondary Offering
Hunter Point Capital’s Minority Investment in L Catterton
Latham & Watkins represents L Catterton in the transaction. L Catterton has announced a strategic partnership with Hunter Point Capital. HPC has made a passive minority investment...
Rivian Automotive’s $1.3 Billion Green Convertible Senior Notes Offering
Latham & Watkins advised Rivian on the offering. Rivian Automotive, Inc. (Nasdaq: RIVN), announced the pricing of its offering of $1,300,000,000 aggregate principal amount of 4.625%...
Roivant Sciences’ $230 Million Common Shares Offering
Davis Polk & Wardwell represented Roivant Sciences, while Latham & Watkins represented the underwriters in the offering. Roivant Sciences (Nasdaq: ROIV) has announced its $230 million...
Driven Brands’ $225.3 Million Secondary Offering
Paul, Weiss, Rifkind, Wharton & Garrison advised Driven Brands Holdings Inc. and selling stockholders Driven Equity LLC and RC IV Cayman ICW Holdings LLC, while Latham...
Zentalis Pharmaceuticals’ $200.2 Million Common Stock Offering
Latham & Watkins represented Zentalis Pharmaceuticals in the transaction. Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting...
Pfizer’s $25 Million Equity Investment in Zentalis Pharmaceuticals
Latham & Watkins represented Zentalis Pharmaceuticals in the transaction. Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological...
The Vita Coco Company’s $173 Million Initial Public Offering
Latham & Watkins represented The Vita Coco Company, Inc. in the offering. The Vita Coco Company, Inc., a leading platform of high-growth better-for-you brands formerly known as...
Rivian Automotive’s Initial Public Offering
Latham & Watkins advised Rivian Automotive, while Skadden, Arps, Slate, Meagher & Flom advised the underwriters in the Initial Public Offering. Rivian Automotive, Inc. has announced its...
Global-e Online’s $883 Million Shares Offering
Latham & Watkins advised Global-e Online on the deal, while Gornitzky represented the underwriters. Global-e Online Ltd. announced the pricing of its underwritten secondary offering by certain...
Driven Brands’ $407 Million Secondary Offering
Latham & Watkins represented the underwriters in the offering. Driven Brands Holdings Inc. has announced the pricing of the underwritten secondary public offering of 12 million...
Zentalis Pharmaceuticals’ $150.4 Million Common Stock Offering
Latham & Watkins LLP represented Zentalis Pharmaceuticals in the offering. Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting...